India Sulfadiazine Market to grow at a steady rate During the Forecast Period
Growing prevalence of
microbial infections is expected to drive the growth of India Sulfadiazine
market.
According
to TechSci Research report, “India
Sulfadiazine Market By Product Type (OTC v/s Prescription), By Route of
Administration (Oral, Topical, Intravenous), By Source (In-house v/s Contract
Manufacturing Organizations), By Form (Tablet, Capsule, Cream, Injection,
Others), By Distribution Channel (Online v/s Offline), By Application (Urinary
Tract Infections, Ear Infections, Meningitis, Malaria, Toxoplasmosis, Others), By
End User (Adult v/s Pediatric), By Company, By Region, Forecast &
Opportunities, FY2026”, the India sulfadiazine market
is expected to grow at a steady rate during the forecast period on account of the
extensive use of the medication in treatment of urinary tract infections,
burns, among others. However, side effects such as nausea, loss of appetite,
dizziness, among others associated with the consumption of sulfadiazine can
hamper the market growth through FY2026. Furthermore, the drug cannot be
administered to patients suffering from kidney diseases, liver problems, among
others. Also, the drug is ineffective against viral infections such as common
cold, flu, among others.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on" India Sulfadiazine
Market "
https://www.techsciresearch.com/report/india-sulfadiazine-market/5153.html
The India sulfadiazine market is segmented based on product type, route
of administration, source, form, distribution channel, application, end user,
company and region. Based on source, the market can be split into in-house and
contract manufacturing organizations. The contract manufacturing organizations
segment is expected to witness significant growth during the forecast period.
This can be attributed to the increased outsourcing activities by the major
companies in order to focus on their R&D activity and expansion plans.
Additionally, contract manufacturing organizations offer greater customer satisfaction,
competitive pricing and can provide bulk orders in lesser duration. Based on distribution, the market can be split into
online and offline. The offline channel is expected to dominate the market
owing to the consumer preference for buying medicines from a pharmacy or drug
store. The online segment is also expected to register significant growth over
the next few years. This can be ascribed to the emergence of several online
pharmacies and doorstep drug delivery e-commerce platforms in the country.
Abbott India Ltd., Boehringer Ingelheim India Private Ltd., Novartis
India Ltd., Emcure Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd.,
Anuh Pharma Ltd., Anuja Healthcare Ltd., Salvi Chemical Industries Ltd., Centurion
Laboratories Private Ltd., Pfizer Ltd. and others are some of the leading
players operating in India sulfadiazine market. Companies operating in the
market are using Go-To-Market strategies such as Pharma licensing deals, product
launches, mergers and acquisitions and research collaborations to boost their
share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5153
Customers can also
request for 10% free customization on this report.
“India sulfadiazine market is expected to
witness growth during the forecast period on account of the supportive government
policies and schemes such as production linked incentive scheme, bulk drug
manufacturing parks, among others. Additionally, China plus one strategy, Vocal
for Local, Aatmanirbhar Bharat, among others are further expected to create
lucrative opportunities for market growth through FY2026.” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Sulfadiazine Market By
Product Type (OTC v/s Prescription), By Route of Administration (Oral, Topical,
Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By
Form (Tablet, Capsule, Cream, Injection, Others), By Distribution Channel
(Online v/s Offline), By Application (Urinary Tract Infections, Ear Infections,
Meningitis, Malaria, Toxoplasmosis, Others), By End User (Adult v/s Pediatric),
By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India sulfadiazine
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India sulfadiazine market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]